Experimental Rhinovirus Infection as a Human Model of Chronic Obstructive Pulmonary Disease Exacerbation

被引:292
作者
Mallia, Patrick [1 ,2 ]
Message, Simon D. [1 ,2 ]
Gielen, Vera [1 ]
Contoli, Marco [1 ,3 ]
Gray, Katrina [1 ,2 ]
Kebadze, Tatiana [1 ]
Aniscenko, Julia [1 ]
Laza-Stanca, Vasile [1 ]
Edwards, Michael R. [1 ]
Slater, Louise [1 ]
Papi, Alberto [3 ]
Stanciu, Luminita A. [1 ]
Kon, Onn M. [1 ,2 ]
Johnson, Malcolm [4 ]
Johnston, Sebastian L. [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Dept Resp Med, Natl Heart & Lung Inst, London W2 1PG, England
[2] Imperial Coll Healthcare Natl Hlth Serv Trust, London, England
[3] Univ Ferrara, Res Ctr Asthma & Chron Obstruct Pulm Dis, I-44100 Ferrara, Italy
[4] GlaxoSmithKline, Uxbridge, Middx, England
基金
英国惠康基金; 英国医学研究理事会;
关键词
disease exacerbation; respiratory tract infections; COPD; rhinovirus; AIRWAY INFLAMMATION; RESPIRATORY VIRUSES; LUNG-FUNCTION; EPITHELIAL-CELLS; MARKERS; FLUTICASONE; SALMETEROL; BACTERIAL; SYMPTOMS; CYTOKINE;
D O I
10.1164/rccm.201006-0833OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rationale: Respiratory virus infections are associated with chronic obstructive pulmonary disease (COPD) exacerbations, but a causative relationship has not been proven. Studies of naturally occurring exacerbations are difficult and the mechanisms linking virus infection to exacerbations are poorly understood. We hypothesized that experimental rhinovirus infection in subjects with COPD would reproduce the features of naturally occurring COPD exacerbations and is a valid model of COPD exacerbations. Objectives: To evaluate experimental rhinovirus infection as a model of COPD exacerbation and to investigate the mechanisms of virus-induced exacerbations. Methods: We used experimental rhinovirus infection in 13 subjects with COPD and 13 nonobstructed control subjects to investigate clinical, physiologic, pathologic, and antiviral responses and relationships between virus load and these outcomes. Measurements and Main Results: Clinical data; inflammatory mediators in blood, sputum, and bronchoalveolar lavage; and viral load in nasal lavage, sputum, and bronchoalveolar lavage were measured at baseline and after infection with rhinovirus 16. After rhinovirus infection subjects with COPD developed lower respiratory symptoms, airflow obstruction, and systemic and airway inflammation that were greater and more prolonged compared with the control group. Neutrophil markers in sputum related to clinical outcomes and virus load correlated with inflammatory markers. Virus load was higher and IFN production by bronchoalveolar lavage cells was impaired in the subjects with COPD. Conclusions: We have developed a new model of COPD exacerbation that strongly supports a causal relationship between rhinovirus infection and COPD exacerbations. Impaired IFN production and neutrophilic inflammation may be important mechanisms in virus-induced COPD exacerbations.
引用
收藏
页码:734 / 742
页数:9
相关论文
共 47 条
[1]   Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease [J].
Aaron, SD ;
Angel, JB ;
Lunau, M ;
Wright, K ;
Fex, C ;
Le Saux, N ;
Dales, RE .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 163 (02) :349-355
[2]  
[Anonymous], 1994, RESP MED, V88, P165
[3]   Experimental rhinovirus infection in volunteers [J].
Bardin, PG ;
Sanderson, G ;
Robinson, BS ;
Holgate, ST ;
Tyrrell, DAJ .
EUROPEAN RESPIRATORY JOURNAL, 1996, 9 (11) :2250-2255
[4]   Respiratory viral infections in patients with chronic, obstructive pulmonary disease [J].
Beckham, JD ;
Cadena, A ;
Lin, JJ ;
Piedra, PA ;
Glezen, WP ;
Greenberg, SB ;
Atmar, RL .
JOURNAL OF INFECTION, 2005, 50 (04) :322-330
[5]   Induced sputum cell counts in healthy adults [J].
Belda, J ;
Leigh, R ;
Parameswaran, K ;
O'Byrne, PM ;
Sears, MR ;
Hargreave, FE .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 161 (02) :475-478
[6]   Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations [J].
Bhowmik, A ;
Seemungal, TAR ;
Sapsford, RJ ;
Wedzicha, JA .
THORAX, 2000, 55 (02) :114-120
[7]   Serum amyloid A is a biomarker of acute exacerbations of chronic obstructive pulmonary disease [J].
Bozinovski, Steven ;
Hutchinson, Anastasia ;
Thompson, Michelle ;
MacGregor, Lochlan ;
Black, James ;
Giannakis, Eleni ;
Karlsson, Anne-Sophie ;
Silvestrini, Roger ;
Smallwood, David ;
Vlahos, Ross ;
Irving, Louis B. ;
Anderson, Gary P. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 177 (03) :269-278
[8]   Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial [J].
Calverley, P ;
Pauwels, R ;
Vestbo, J ;
Jones, P ;
Pride, N ;
Gulsvik, A ;
Anderson, J ;
Maden, C .
LANCET, 2003, 361 (9356) :449-456
[9]   Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease [J].
Calverley, Peter M. A. ;
Anderson, Julie A. ;
Celli, Bartolome ;
Ferguson, Gary T. ;
Jenkins, Christine ;
Jones, Paul W. ;
Yates, Julie C. ;
Vestbo, Jorgen ;
Calverley, P. M. A. ;
Anderson, J. A. ;
Celli, B. ;
Ferguson, G. T. ;
Jenkins, C. ;
Jones, P. W. ;
Knobil, K. ;
Yates, J. C. ;
Vestbo, J. ;
Cherniack, R. ;
Similowski, T. ;
Cleland, J. ;
Whitehead, A. ;
Wise, R. ;
McGarvey, L. ;
John, M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (08) :775-789
[10]   Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials [J].
Calverley, Peter M. A. ;
Rabe, Klaus F. ;
Goehring, Udo-Michael ;
Kristiansen, Soren ;
Fabbri, Leonardo M. ;
Martinez, Fernando J. .
LANCET, 2009, 374 (9691) :685-694